NYSE American: EDVA

Endovia Health Sciences, Inc. (EDVA)

Endovia Health Sciences, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE American under the ticker EDVA. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
EDVA
Exchange
NYSE American
SEC CIK
1553788
Official filings
SEC EDGAR

Research EDVA

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Endovia Health Sciences, Inc.'s stock ticker?

Endovia Health Sciences, Inc. trades under the ticker symbol EDVA on NYSE American. Its SEC Central Index Key (CIK) is 1553788.

Where can I read Endovia Health Sciences, Inc.'s SEC filings?

The EDVA SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Endovia Health Sciences, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze EDVA's financial statements?

The EDVA Financials page shows Endovia Health Sciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does EDVA compare with its peers and the market?

The EDVA Peer Comparison page lines Endovia Health Sciences, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.